📣 VC round data is live. Check it out!

Oxiquim Valuation Multiples

Discover revenue and EBITDA valuation multiples for Oxiquim and similar public comparables like NL Industries, Messer Tehnogas, Natac Natural Ingredients, Valhi and more.

Oxiquim Overview

About Oxiquim

Oxiquim SA focuses on the marketing of chemical products and the provision of services related to the chemical sector. It is engaged in the production, transformation, sale, export, and distribution of all types of chemical, petrochemical, pharmaceutical, cosmetic, and general chemical products. The company's other business activities include the provision of engineering and maintenance services, the operation and exploitation of maritime terminals, and the production and sale of resins and adhesive mixtures. The company's operating segments are; Commercial which derives maximum revenue, and Services.


Founded

1980

HQ

Chile

Employees

428

Sectors

Financials (FY)

Revenue: $263M
EBITDA: $42M

EV

$398M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Oxiquim Financials

Oxiquim reported last fiscal year revenue of $263M and EBITDA of $42M.

In the same fiscal year, Oxiquim generated $92M in gross profit, $42M in EBITDA, and $29M in net income.


Oxiquim P&L

In the most recent fiscal year, Oxiquim reported revenue of $263M and EBITDA of $42M.

Oxiquim is profitable as of last fiscal year, with gross margin of 35%, EBITDA margin of 16%, and net margin of 11%.

See analyst estimates for Oxiquim
Last FY202320242025202620272028
Revenue$263M$238M$261M$263M
Gross Profit$92M$85M$95M$92M
Gross Margin35%36%36%35%
EBITDA$42M$40M$44M$42M
EBITDA Margin16%17%17%16%
EBIT Margin13%13%15%13%
Net Profit$29M$27M$29M$29M
Net Margin11%11%11%11%
Net Debt$52M

Financial data powered by Morningstar, Inc.

Oxiquim Stock Performance

Oxiquim has current market cap of $344M, and enterprise value of $398M.

Market Cap Evolution


Oxiquim's stock price is $13.82.

Oxiquim share price increased by 0.3% in the last 30 days, and by 25.3% in the last year.

Oxiquim has an EPS (earnings per share) of $1.16.

See more trading valuation data for Oxiquim
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$398M$344M-0.3%0.3%0.2%25.3%$1.16

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Oxiquim Valuation Multiples

Oxiquim trades at 1.5x EV/Revenue multiple, and 9.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Oxiquim

Oxiquim Financial Valuation Multiples

As of May 20, 2026, Oxiquim has market cap of $344M and EV of $398M.

Oxiquim has a P/E ratio of 11.9x.

Last FY202320242025202620272028
EV/Revenue1.5x1.7x1.5x1.5x
EV/EBITDA9.5x9.9x9.0x9.5x
EV/EBIT11.9x12.7x10.5x11.9x
EV/Gross Profit4.3x4.7x4.2x4.3x
P/E11.9x13.0x11.8x11.9x
EV/FCF15.6x12.9x19.3x15.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Oxiquim Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Oxiquim Margins & Growth Rates

In the most recent fiscal year, Oxiquim reported gross margin of 35%, EBITDA margin of 16%, and net margin of 11%.

See estimated margins and future growth rates for Oxiquim

Oxiquim Margins

Last FY20242025202720282029
Gross Margin35%36%35%
EBITDA Margin16%17%16%
EBIT Margin13%15%13%
Net Margin11%11%11%
FCF Margin10%8%10%

Oxiquim Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth10%1%
Gross Profit Growth11%(3%)
EBITDA Growth10%(5%)
EBIT Growth21%(12%)
Net Profit Growth10%(1%)
FCF Growth(33%)24%

Data powered by FactSet, Inc. and Morningstar, Inc.

Oxiquim Operational KPIs

Oxiquim's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Oxiquim
Last FY202320242025202620272028
Revenue per Employee$0.6M
Opex per Employee$0.1M
S&M Expenses to Revenue3%4%3%3%
G&A Expenses to Revenue7%7%8%7%
Opex to Revenue22%23%22%22%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Oxiquim Competitors

Oxiquim competitors include NL Industries, Messer Tehnogas, Natac Natural Ingredients, Valhi, Ercros, Alto Ingredients, Orion SA, Samyang Holdings, Itafos and Sniezka.

Most Oxiquim public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
NL Industries1.6x1.6x(5.3x)
Messer Tehnogas1.1x3.0x
Natac Natural Ingredients7.5x6.5x25.4x20.3x
Valhi0.4x0.4x10.1x
Ercros0.7x0.7x64.4x43.4x
Alto Ingredients0.5x0.5x9.0x8.3x
Orion SA0.7x0.7x5.4x5.9x
Samyang Holdings0.3x3.1x

This data is available for Pro users. Sign up to see all Oxiquim competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Oxiquim

When was Oxiquim founded?Oxiquim was founded in 1980.
Where is Oxiquim headquartered?Oxiquim is headquartered in Chile.
How many employees does Oxiquim have?As of today, Oxiquim has over 428 employees.
Is Oxiquim publicly listed?Yes, Oxiquim is a public company listed on Bolsa de Santiago.
What is the stock symbol of Oxiquim?Oxiquim trades under OXIQUIM ticker.
When did Oxiquim go public?Oxiquim went public in 2015.
Who are competitors of Oxiquim?Oxiquim main competitors include NL Industries, Messer Tehnogas, Natac Natural Ingredients, Valhi, Ercros, Alto Ingredients, Orion SA, Samyang Holdings, Itafos, Sniezka.
What is the current market cap of Oxiquim?Oxiquim's current market cap is $344M.
What is the current revenue of Oxiquim?Oxiquim's last fiscal year revenue is $263M.
What is the current EV/Revenue multiple of Oxiquim?Current revenue multiple of Oxiquim is 1.5x.
Is Oxiquim profitable?No, Oxiquim is not profitable.
How many companies Oxiquim has acquired to date?Oxiquim hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Oxiquim has invested to date?Oxiquim hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Oxiquim

Lists including Oxiquim

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial